J
Jens Dreier
Researcher at Ruhr University Bochum
Publications - 115
Citations - 3849
Jens Dreier is an academic researcher from Ruhr University Bochum. The author has contributed to research in topics: Vitamin D and neurology & Streptococcus gallolyticus. The author has an hindex of 35, co-authored 114 publications receiving 3472 citations. Previous affiliations of Jens Dreier include Bielefeld University & University of Münster.
Papers
More filters
Journal ArticleDOI
Effect of vitamin D supplementation on testosterone levels in men.
Stefan Pilz,S. Frisch,H. Koertke,Joachim Kuhn,Jens Dreier,Barbara Obermayer-Pietsch,Elisabeth Wehr,Armin Zittermann +7 more
TL;DR: It is suggested that vitamin D supplementation might increase testosterone levels in healthy overweight men undergoing a weight reduction program who participated in a randomized controlled trial.
Journal Article
Identification of the Integral Membrane Protein RM3/1 on Human Monocytes as a Glucocorticoid-Inducible Member of the Scavenger Receptor Cysteine-Rich Family (CD163)
TL;DR: It is shown for the first time that CD163 is significantly up-regulated by glucocorticoids, suggesting that it might play an important role in inflammatory processes.
Journal ArticleDOI
Use of Bacteriophage MS2 as an Internal Control in Viral Reverse Transcription-PCR Assays
TL;DR: Various real-time RT-PCRs utilizing the coliphage MS2 replicase gene, which differ in detection format, amplicon size, and efficiency of amplification are designed, which demonstrate low variability and can be applied in various RT- PCR assays.
Journal ArticleDOI
Novel approach for detection of hepatitis E virus infection in German blood donors
TL;DR: The NAT method provides a sensitive possibility for HEV testing in connection with raising concerns regarding blood safety, and is compared with different nucleic acid amplification technique (NAT) methods for the detection of HEV in blood components.
Journal ArticleDOI
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
Armin Zittermann,Jana B. Ernst,Sylvana Prokop,Uwe Fuchs,Jens Dreier,Joachim Kuhn,Cornelius Knabbe,Ingvild Birschmann,Uwe Schulz,Heiner K. Berthold,Stefan Pilz,Ioanna Gouni-Berthold,Jan Gummert,Marcus Dittrich,Jochen Börgermann +14 more
TL;DR: A daily vitamin D dose of 4000 IU did not reduce mortality in patients with advanced HF but was associated with a greater need for MCS implants, which indicates caution regarding long-term supplementation with moderately high vitamin D doses.